An atlas of genetic influences on human blood metabolites

Shin et al., Nature Genetics, 2014 [ Article | SI Text ]

Locus 135: APOE (19q13.32)

Meta-analysis summary statistics for associations meeting genome-wide significance
Lead SNPBiochemicalsEA/OANtotalEAFEffect (SE)PmetaDetails
rs445925 X-11820 / cholesterol A/G 5510 0.08 0.089 (0.009) 4.65·10-23 show

EA = effect allele; OA = other allele; EAF = frequency of effect allele;

Summary of biological annotations
SNPrs445925
Chromosomal locationChr19: 50,107,480 (19q13.32)
Gene (distance)APOE (2,991)
Predicted causal geneAPOE|APOC1|APOC2
Gene/protein classification-
Metabolite (Pathway)X-11820 (Unknown)
cholesterol (Sterol, Steroid; Lipid)
Biochemical locus-metabolite relationshipAPOE|APOC1|APOC2 locus has been associated with LDL, HDL and total cholesterol levels in previous GWAS [20686565]. Ratio interpretation: n/a.
eQTL associationsAPOE (F), APOE (S), APOC2 (L) †

† F = adipose tissue; S = skin cells; L = lymphoblastoid cells; H = liver cells;

Medical information
Complex trait associationsApolipoprotein Levels [23031429]; Cardiovascular disease risk factors [20838585]; Carotid intima media thickness [21909108]; Lipoprotein-associated phospholipase A2 activity and mass [23118302]
Known metabolite associationsMetabolite levels [22916037]
Inborn error of metabolismHyperlipidemia type 3

Pharmacological information
ChEMBL ID-
Drug information -

Locus information for top associated metabolite

HapMap2 imputation

Imputation HapMap

1KGP imputation

Imputation 1KGP

 

Network view
Association map